Namax Medical AB

Active
559260-1263Limited company (AB)Registered 2020STOCKHOLM

Key figures

283 000 kr+7 175,0%
Revenue 2025
+19,1%
Average annual growth 2020–2025
-200 k0200 k400 k600 k202020212022202320242025

Key figures

2025

Summary: Namax Medical AB

What kind of company is it?

Namax Medical AB (org. no. 559260-1263) is a limited company (AB). The company was registered in 2020 and has existed for 6 years. Registered seat: Stockholm. Industry according to Statistics Sweden: specialist medical practice activities, not at hospitals (SNI 86222).

How is the company doing financially?

Net sales in financial year 2025 were 283 000 kr. From 2020 to 2025, net sales grew by an average of 19,1 % per year. Net profit for 2025 was 137 315 kr (48,5 % of net sales). The company was profitable in 5 of the 6 reported financial years. At the end of financial year 2025, total assets were 319 000 kr and equity 246 445 kr (equity ratio 77,3 %). The annual report for 2025 proposes a dividend of 200 000 kr.

Where does the data come from and how up to date is it?

Company details and digitally filed annual reports come from the open data of the Swedish Companies Registration Office (Bolagsverket) and the industry code from Statistics Sweden (CC BY 2.5 SE); bolagsprofil.se updates them daily. The latest annual report is signed by 3 people. Data as of 2026-11-16. Changes, averages and ratios are calculated by bolagsprofil.se from open data and are not an official assessment.

Dividend

from the annual report
2025

Proposed dividend 200 000 kr.

Summary of annual reports2020–2025
20212022202320242025
Sales revenue567 000122 00045 000−4 000283 000
Profit for the reporting year398 95743 12517 760−38 867137 315
Retained earnings of previous periods—————
Total assets567 733417 873260 137221 167319 000
Total liabilities135 62092 63612 14012 03772 555
Total equity432 113325 237247 997209 130246 445
Employees—————
Proposed dividend————200 000

A dash (—) means the report has not been filed or the line is not reported; 0 is a zero stated in the report.